2beta-Hydrocyfukinone

Details

Top
Internal ID 44aec378-96a7-491c-8bd2-56aa906b824e
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids > Eremophilane, 8,9-secoeremophilane and furoeremophilane sesquiterpenoids
IUPAC Name (4aR,5S,7R,8aR)-7-hydroxy-4a,5-dimethyl-3-propan-2-ylidene-4,5,6,7,8,8a-hexahydro-1H-naphthalen-2-one
SMILES (Canonical) CC1CC(CC2C1(CC(=C(C)C)C(=O)C2)C)O
SMILES (Isomeric) C[C@H]1C[C@H](C[C@H]2[C@@]1(CC(=C(C)C)C(=O)C2)C)O
InChI InChI=1S/C15H24O2/c1-9(2)13-8-15(4)10(3)5-12(16)6-11(15)7-14(13)17/h10-12,16H,5-8H2,1-4H3/t10-,11+,12+,15+/m0/s1
InChI Key YIVBFYZTSPNDJU-FUTJPDQTSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H24O2
Molecular Weight 236.35 g/mol
Exact Mass 236.177630004 g/mol
Topological Polar Surface Area (TPSA) 37.30 Ų
XlogP 3.00
Atomic LogP (AlogP) 3.10
H-Bond Acceptor 2
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of 2beta-Hydrocyfukinone

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.9296 92.96%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability + 0.5571 55.71%
Subcellular localzation Mitochondria 0.6788 67.88%
OATP2B1 inhibitior - 0.8462 84.62%
OATP1B1 inhibitior + 0.9427 94.27%
OATP1B3 inhibitior + 0.9724 97.24%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.7250 72.50%
BSEP inhibitior - 0.8276 82.76%
P-glycoprotein inhibitior - 0.9250 92.50%
P-glycoprotein substrate - 0.8616 86.16%
CYP3A4 substrate + 0.5418 54.18%
CYP2C9 substrate + 1.0000 100.00%
CYP2D6 substrate - 0.8653 86.53%
CYP3A4 inhibition - 0.7523 75.23%
CYP2C9 inhibition - 0.8786 87.86%
CYP2C19 inhibition - 0.6293 62.93%
CYP2D6 inhibition - 0.9468 94.68%
CYP1A2 inhibition - 0.8767 87.67%
CYP2C8 inhibition - 0.9333 93.33%
CYP inhibitory promiscuity - 0.8151 81.51%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9013 90.13%
Carcinogenicity (trinary) Non-required 0.5565 55.65%
Eye corrosion - 0.9919 99.19%
Eye irritation + 0.5885 58.85%
Skin irritation + 0.5940 59.40%
Skin corrosion - 0.9680 96.80%
Ames mutagenesis - 0.6400 64.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5836 58.36%
Micronuclear - 0.9000 90.00%
Hepatotoxicity + 0.6337 63.37%
skin sensitisation + 0.6614 66.14%
Respiratory toxicity - 0.5111 51.11%
Reproductive toxicity + 0.8333 83.33%
Mitochondrial toxicity + 0.7250 72.50%
Nephrotoxicity + 0.5936 59.36%
Acute Oral Toxicity (c) III 0.8099 80.99%
Estrogen receptor binding - 0.6207 62.07%
Androgen receptor binding - 0.5670 56.70%
Thyroid receptor binding - 0.5669 56.69%
Glucocorticoid receptor binding - 0.6548 65.48%
Aromatase binding - 0.7505 75.05%
PPAR gamma - 0.7658 76.58%
Honey bee toxicity - 0.7913 79.13%
Biodegradation - 0.6750 67.50%
Crustacea aquatic toxicity + 0.5600 56.00%
Fish aquatic toxicity + 0.9902 99.02%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.98% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.83% 91.11%
CHEMBL2581 P07339 Cathepsin D 92.33% 98.95%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 88.59% 96.77%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.07% 97.25%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 84.56% 85.14%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 84.29% 95.56%
CHEMBL1806 P11388 DNA topoisomerase II alpha 83.86% 89.00%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 82.20% 99.23%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.25% 86.33%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.17% 97.09%
CHEMBL340 P08684 Cytochrome P450 3A4 80.10% 91.19%

Cross-Links

Top
PubChem 102208390
NPASS NPC310513
LOTUS LTS0003503
wikiData Q105349053